Related Experiment Video
Updated: May 21, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Migraine and depression comorbidity: antidepressant options
1Clinical and Oncologic Psychology Unit, University of Turin, Turin, Italy. riccardo.torta@unito.it
Summary
Migraine and depression share neurobiological pathways. Tricyclic antidepressants are more effective for both conditions than SNRIs and SSRIs, but have dose-limiting side effects.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Migraine and mood depression are clinically related, sharing neurobiological mechanisms.
- These mechanisms involve neurotransmission and inflammation.
- Effective treatment requires considering efficacy, safety, and tolerability.
Purpose of the Study:
- To compare the efficacy of different antidepressant classes in treating both depression and migraine.
- To evaluate the side effect profiles of antidepressants used for comorbid depression and migraine.
Main Methods:
- Review of existing literature on antidepressant efficacy for depression and migraine.
- Analysis of comparative effectiveness data for Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and Selective Serotonin Reuptake Inhibitors (SSRIs).
Main Results:
- Antidepressants show comparable efficacy for depressive disorders.
- Efficacy for headache treatment varies significantly among antidepressant classes.
- Tricyclic antidepressants demonstrate greater efficacy for migraine than SNRIs and SSRIs.
Conclusions:
- Tricyclic antidepressants are more effective for treating comorbid depression and migraine.
- The choice of antidepressant must balance efficacy with potential dose-limiting side effects.
- Further research may explore optimized therapeutic strategies for these overlapping conditions.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...